Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,222
datasets available to search
ShareScore release 0.9.0
Dataset results
6,222 results for “small cells”
Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT01350817. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)
ClinicalTrials.gov study NCT03976323. IPD Sharing: YES. Countries: 20. Publications: 1.
Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00107172. IPD Sharing: Not stated. Countries: 2. Publications: 5.
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
ClinicalTrials.gov study NCT00551369. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT02613507. IPD Sharing: Not stated. Countries: 4. Publications: 2.
PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib
ClinicalTrials.gov study NCT00548093. IPD Sharing: YES. Countries: 1. Publications: 1.
LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT00805194. IPD Sharing: Not stated. Countries: 27. Publications: 2.
A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen
ClinicalTrials.gov study NCT02066636. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
ClinicalTrials.gov study NCT04685135. IPD Sharing: NO. Countries: 23. Publications: 1.
Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00301808. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT01017874. IPD Sharing: Not stated. Countries: 5. Publications: 3.
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
ClinicalTrials.gov study NCT03811002. IPD Sharing: YES. Countries: 2. Publications: 2.
A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations
ClinicalTrials.gov study NCT02588261. IPD Sharing: YES. Countries: 23. Publications: 1.
Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers
ClinicalTrials.gov study NCT02487095. IPD Sharing: NO. Countries: 1. Publications: 4.
A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03285763. IPD Sharing: Not stated. Countries: 24. Publications: 2.
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04194944. IPD Sharing: YES. Countries: 26. Publications: 4.
U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03260491. IPD Sharing: YES. Countries: 6. Publications: 2.
Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)
ClinicalTrials.gov study NCT00148798. IPD Sharing: Not stated. Countries: 28. Publications: 5.
Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00921310. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT05089734. IPD Sharing: NO. Countries: 20. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.